Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial.
about
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathyTreatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.Numbness and paresthesia in bilateral toes and soles, and disproportional sweating restricted to face and trunk are suitable symptoms useful for the diagnosis of diabetic symmetric polyneuropathyPregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.Factors predicting adverse events associated with pregabalin administered for neuropathic pain reliefA comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain.Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials.Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan.Transforming pain medicine: adapting to science and societyPregabalin in neuropathic pain: evidences and possible mechanisms.Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators.Drug safety evaluation of pregabalin.Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy.Pharmacological treatment of chronic non-cancer pain in pediatric patients.An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis.Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: a randomized, placebo-controlled trial.Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials.Aromatherapy Massage for Neuropathic Pain and Quality of Life in Diabetic Patients.Influence of analgesic active 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one on the antioxidant status, glucose utilization and lipid accumulation in some in vitro and ex vivo assays.Improvement in pain severity category in clinical trials of pregabalinEffects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials.Activation of Antioxidative Functions by Radon Inhalation Enhances the Mitigation Effects of Pregabalin on Chronic Constriction Injury-Induced Neuropathic Pain in Mice.Evaluation of postoperative pregabalin for attenuation of postoperative shoulder pain after thoracotomy in patients with lung cancer, a preliminary result.Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers.Efficacy and Safety of Pregabalin for the Treatment of Neuropathic Pain in Patients Undergoing Hemodialysis.Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia.Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain.Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials.Cross-over, open-label trial of the effects of gabapentin versus pregabalin on painful peripheral neuropathy and health-related quality of life in haemodialysis patients.Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials.Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta-analysis.Impact of pregabalin treatment on pain, pain-related sleep interference and general well-being in patients with neuropathic pain: a non-interventional, multicentre, post-marketing study.Does Duration of Neuropathic Pain Impact the Effectiveness of Pregabalin?Executive summary of the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain: second edition by the Japanese Society of Pain Clinicians.
P2860
Q24621657-83F1C6B0-D785-42B0-AA3B-4BECCA472C51Q31170335-68B99A4B-8D7A-41CF-BDFE-37DEA05A319BQ33585572-74326F8C-09F0-41E5-8C6F-C407F731D13AQ33585576-6F2D9080-4996-46F3-9768-F0C667E9A864Q33949565-3C897192-1239-4B7D-8C7C-B7D080164A66Q34411257-85956CDD-4BCD-49D3-B4FE-61D03042C649Q34756216-10DFBE36-FC23-4304-8422-7374C8A304DAQ35061149-041B95FB-3CC0-4213-BDC9-E5E9521D109DQ35694450-4493EBA3-7A5F-464D-AE8D-C2ECCA861DE4Q35934879-A13EE6EF-BF93-4D4B-A7BE-EF1A1AF6F262Q36926952-FA7045B2-E9F6-4999-B1DC-3BEA203E8F14Q37559818-DAAB46A6-1035-440B-95C3-F6E0B994093CQ37879583-9F9F9B6D-4D67-48A4-AEF2-1047A24CEBC6Q37999052-4E870866-FE18-460A-983F-619AB0F73A1CQ38093664-F3CB7CDC-4101-4A0B-9EC3-A83668494485Q38258949-0AF9A32F-19F9-45A4-A1FA-58A5873299B8Q38307489-45B6C1C5-375C-46B8-8A3D-6D0895FC9E35Q38373631-A177542F-495E-4A98-9345-D6EAC5B3791DQ38386200-CEC0DD08-B7B6-44BC-81EB-1C2597323D40Q38631470-3BC59F29-9A20-453C-81D5-14DC07CCDBD5Q38730152-9AE29C9C-7594-457B-BE1C-D5566441B252Q39037121-D5AD2617-6ED0-42E7-A6D6-5015FF65EE94Q39165164-F95793B3-539A-4631-BDD3-EBB0297358A3Q39167580-31D05C91-3DFA-42B3-A341-55CBC38127B8Q39177759-6FEDEA4A-94B2-4DFF-8711-9232D25F938EQ39201931-243B5FFB-3339-438A-9587-43824D9C8D87Q39215784-B4948EAE-D79C-42DC-BE03-0FA14D9D7C02Q39252064-9994B677-A900-40FE-8941-A8CBB1DB32BAQ39359678-D325863A-697E-4416-BE4F-98DDC792043CQ40389580-57F05F72-A233-43D8-93A4-CF3EFCA9CCE4Q42660985-30F97CBB-C898-418C-A4AE-10EFF4E64E1EQ42679169-C6A54DBE-13C3-488B-B4F9-783FDAEAB7BBQ42817278-718CD75B-DF35-4B38-A44C-A44C59D0F472Q43075748-581C17EB-96CA-487A-9372-D3C3D8C12760Q44252190-3146E2C1-2EFF-4EE6-917D-9FCC631C3215Q48000334-A6D244E0-A588-4AEA-82A5-E77BE7BB4CA9Q48021450-073EC70E-493F-4647-BB4D-2A615E949CCCQ48308914-E83EFF4B-D210-4D71-B5AD-074753EEE9D7Q51826259-34DF9555-207A-4064-BECA-33A1106C6E7CQ54218406-FCD6D795-776E-403C-8BAB-BA74A6D4C3E3
P2860
Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Efficacy and safety of pregaba ...... ind, placebo-controlled trial.
@en
Efficacy and safety of pregaba ...... ind, placebo-controlled trial.
@nl
type
label
Efficacy and safety of pregaba ...... ind, placebo-controlled trial.
@en
Efficacy and safety of pregaba ...... ind, placebo-controlled trial.
@nl
prefLabel
Efficacy and safety of pregaba ...... ind, placebo-controlled trial.
@en
Efficacy and safety of pregaba ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of pregaba ...... ind, placebo-controlled trial.
@en
P2093
S Yagihashi
T Yoshiyama
P2860
P304
P356
10.1111/J.1464-5491.2010.03152.X
P577
2011-01-01T00:00:00Z